These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 33073512)

  • 1. Obesity and COVID-19: A jigsaw puzzle with still missing pieces.
    Michalakis K; Panagiotou G; Ilias I; Pazaitou-Panayiotou K
    Clin Obes; 2021 Feb; 11(1):e12420. PubMed ID: 33073512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intersection between COVID-19 and obesity in the context of an emerging country.
    Pinhel MAS; Watanabe LM; Noronha NY; Junior WS; Nonino CB
    Clin Nutr ESPEN; 2021 Aug; 44():472-474. PubMed ID: 34330509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives.
    Dalamaga M; Christodoulatos GS; Karampela I; Vallianou N; Apovian CM
    Curr Obes Rep; 2021 Sep; 10(3):214-243. PubMed ID: 33909265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and COVID-19 in Latin America: A tragedy of two pandemics-Official document of the Latin American Federation of Obesity Societies.
    Halpern B; Louzada MLDC; Aschner P; Gerchman F; Brajkovich I; Faria-Neto JR; Polanco FE; Montero J; Juliá SMM; Lotufo PA; Franco OH
    Obes Rev; 2021 Mar; 22(3):e13165. PubMed ID: 33230898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality?
    Lockhart SM; O'Rahilly S
    Med; 2020 Dec; 1(1):33-42. PubMed ID: 32838359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention.
    Sharma JR; Yadav UCS
    Obes Res Clin Pract; 2021; 15(2):163-171. PubMed ID: 33509701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Obesity Paradox in Infections and Implications for COVID-19.
    Lavie CJ; Coursin DB; Long MT
    Mayo Clin Proc; 2021 Mar; 96(3):518-520. PubMed ID: 33673900
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
    Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Centrality of Obesity in the Course of Severe COVID-19.
    Liu D; Zhang T; Wang Y; Xia L
    Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa.
    Giorgino F; Bhana S; Czupryniak L; Dagdelen S; Galstyan GR; Janež A; Lalić N; Nouri N; Rahelić D; Stoian AP; Raz I
    Diabetes Res Clin Pract; 2021 Feb; 172():108617. PubMed ID: 33310175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships.
    Popkin BM; Du S; Green WD; Beck MA; Algaith T; Herbst CH; Alsukait RF; Alluhidan M; Alazemi N; Shekar M
    Obes Rev; 2020 Nov; 21(11):e13128. PubMed ID: 32845580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection.
    Pal A; Gowdy KM; Oestreich KJ; Beck M; Shaikh SR
    Front Immunol; 2020; 11():1997. PubMed ID: 32983141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, noncommunicable diseases, and COVID-19: A perfect storm.
    Katzmarzyk PT; Salbaum JM; Heymsfield SB
    Am J Hum Biol; 2020 Sep; 32(5):e23484. PubMed ID: 32798247
    [No Abstract]   [Full Text] [Related]  

  • 14. Pandemics of the 21st Century: The Risk Factor for Obese People.
    Hancková M; Betáková T
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-grade inflammation, CoVID-19, and obesity: clinical aspect and molecular insights in childhood and adulthood.
    Muscogiuri G; Bettini S; Boschetti M; Barrea L; Savastano S; Colao A;
    Int J Obes (Lond); 2022 Jul; 46(7):1254-1261. PubMed ID: 35393519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of obesity on COVID-19 patients.
    Yu W; Rohli KE; Yang S; Jia P
    J Diabetes Complications; 2021 Mar; 35(3):107817. PubMed ID: 33358523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of prior metabolic and bariatric surgery with severity of coronavirus disease 2019 (COVID-19) in patients with obesity.
    Aminian A; Fathalizadeh A; Tu C; Butsch WS; Pantalone KM; Griebeler ML; Kashyap SR; Rosenthal RJ; Burguera B; Nissen SE
    Surg Obes Relat Dis; 2021 Jan; 17(1):208-214. PubMed ID: 33243670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global pandemics interconnected - obesity, impaired metabolic health and COVID-19.
    Stefan N; Birkenfeld AL; Schulze MB
    Nat Rev Endocrinol; 2021 Mar; 17(3):135-149. PubMed ID: 33479538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of SARS-CoV-2 positive cases beyond health-care professionals or social and health-care facilities.
    Deiana G; Azara A; Dettori M; Delogu F; Vargiu G; Gessa I; Arghittu A; Tidore M; Steri G; Castiglia P
    BMC Public Health; 2021 Jan; 21(1):83. PubMed ID: 33413218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and stroke in the COVID19 era.
    Bosque-Varela P; Moscote-Salazar LR; Agrawal A
    Clin Neurol Neurosurg; 2020 Sep; 196():105969. PubMed ID: 32492587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.